Vineet D. Menachery, Ph.D. - Publications

Affiliations: 
2010 Biology & Biomedical Sciences (Immunology) Washington University, Saint Louis, St. Louis, MO 

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Morris DR, Qu Y, Thomason KS, Haas de Mello A, Preble R, Menachery VD, Casola A, Garofalo RP. The impact of RSV/SARS-CoV-2 co-infection on clinical disease and viral replication: insights from a BALB/c mouse model. Biorxiv : the Preprint Server For Biology. PMID 37292863 DOI: 10.1101/2023.05.24.542043  0.378
2023 Qu Y, Haas de Mello A, Morris DR, Jones-Hall YL, Ivanciuc T, Sattler RA, Paessler S, Menachery VD, Garofalo RP, Casola A. SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection. Microbiology Spectrum. e0037823. PMID 37022178 DOI: 10.1128/spectrum.00378-23  0.334
2023 Schindewolf C, Lokugamage K, Vu MN, Johnson BA, Scharton D, Plante JA, Kalveram B, Crocquet-Valdes PA, Sotcheff S, Jaworski E, Alvarado RE, Debbink K, Daugherty MD, Weaver SC, Routh AL, ... ... Menachery VD, et al. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3. Journal of Virology. e0153222. PMID 36722972 DOI: 10.1128/jvi.01532-22  0.41
2022 Schindewolf C, Lokugamage K, Vu MN, Johnson BA, Scharton D, Plante JA, Kalveram B, Crocquet-Valdes PA, Sotcheff S, Jaworski E, Alvarado RE, Debbink K, Daugherty MD, Weaver SC, Routh AL, ... ... Menachery VD, et al. SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3. Biorxiv : the Preprint Server For Biology. PMID 36203546 DOI: 10.1101/2022.09.26.509529  0.361
2022 Plante JA, Machado RRG, Mitchell BM, Shinde DP, Walker J, Scharton D, McConnell A, Saada N, Liu J, Khan B, Campos RK, Johnson BA, Menachery VD, Levine CB, Ren P, et al. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients. Viruses. 14. PMID 36146877 DOI: 10.3390/v14092071  0.344
2022 Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, et al. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13: 4337. PMID 35896528 DOI: 10.1038/s41467-022-31930-z  0.381
2022 Vu MN, Lokugamage KG, Plante JA, Scharton D, Bailey AO, Sotcheff S, Swetnam DM, Johnson BA, Schindewolf C, Alvarado RE, Crocquet-Valdes PA, Debbink K, Weaver SC, Walker DH, Russell WK, ... ... Menachery VD, et al. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 119: e2205690119. PMID 35881779 DOI: 10.1073/pnas.2205690119  0.388
2022 Johnson BA, Zhou Y, Lokugamage KG, Vu MN, Bopp N, Crocquet-Valdes PA, Kalveram B, Schindewolf C, Liu Y, Scharton D, Plante JA, Xie X, Aguilar P, Weaver SC, Shi PY, ... ... Menachery VD, et al. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. Plos Pathogens. 18: e1010627. PMID 35728038 DOI: 10.1371/journal.ppat.1010627  0.331
2022 DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, ... ... Menachery VD, et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature. PMID 35361968 DOI: 10.1038/s41586-022-04690-5  0.49
2021 Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, Ku Z, An Z, Scharton D, Schindewolf C, Widen SG, Menachery VD, Shi PY, Weaver SC. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature. PMID 34818667 DOI: 10.1038/s41586-021-04245-0  0.313
2021 Vanderheiden A, Thomas J, Soung AL, Davis-Gardner ME, Floyd K, Jin F, Cowan DA, Pellegrini K, Shi PY, Grakoui A, Klein RS, Bosinger SE, Kohlmeier JE, Menachery VD, Suthar MS. CCR2 Signaling Restricts SARS-CoV-2 Infection. Mbio. e0274921. PMID 34749524 DOI: 10.1128/mBio.02749-21  0.349
2021 Muruato A, Vu MN, Johnson BA, Davis-Gardner ME, Vanderheiden A, Lokugamage K, Schindewolf C, Crocquet-Valdes PA, Langsjoen RM, Plante JA, Plante KS, Weaver SC, Debbink K, Routh AL, Walker D, ... ... Menachery VD, et al. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge. Plos Biology. 19: e3001284. PMID 34735434 DOI: 10.1371/journal.pbio.3001284  0.409
2021 Vu MN, Menachery VD. Binding and entering: COVID finds a new home. Plos Pathogens. 17: e1009857. PMID 34460863 DOI: 10.1371/journal.ppat.1009857  0.342
2021 Routhu NK, Cheedarla N, Bollimpelli VS, Gangadhara S, Edara VV, Lai L, Sahoo A, Shiferaw A, Styles TM, Floyd K, Fischinger S, Atyeo C, Shin SA, Gumber S, Kirejczyk S, ... ... Menachery VD, et al. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nature Communications. 12: 3587. PMID 34117252 DOI: 10.1038/s41467-021-23942-y  0.315
2021 Lakdawala SS, Menachery VD. Catch me if you can: superspreading of COVID-19. Trends in Microbiology. PMID 34059436 DOI: 10.1016/j.tim.2021.05.002  0.307
2021 Feng S, Heath E, Jefferson B, Joslyn C, Kvinge H, Mitchell HD, Praggastis B, Eisfeld AJ, Sims AC, Thackray LB, Fan S, Walters KB, Halfmann PJ, Westhoff-Smith D, Tan Q, ... Menachery VD, et al. Hypergraph models of biological networks to identify genes critical to pathogenic viral response. Bmc Bioinformatics. 22: 287. PMID 34051754 DOI: 10.1186/s12859-021-04197-2  0.379
2021 Trimarco JD, Heaton BE, Chaparian RR, Burke KN, Binder RA, Gray GC, Smith CM, Menachery VD, Heaton NS. TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2. Plos Pathogens. 17: e1009599. PMID 34043740 DOI: 10.1371/journal.ppat.1009599  0.337
2021 Schäfer A, Gralinski LE, Leist SR, Winkler ES, Hampton BK, Mooney MA, Jensen KL, Graham RL, Agnihothram S, Jeng S, Chamberlin S, Bell TA, Scobey DT, VanBlargan LA, Thackray LB, ... ... Menachery VD, et al. Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species. Biorxiv : the Preprint Server For Biology. PMID 34013261 DOI: 10.1101/2021.05.14.444205  0.514
2021 Muruato A, Vu MN, Johnson BA, Davis-Gardner ME, Vanderheiden A, Lokugmage K, Schindewolf C, Crocquet-Valdes PA, Langsjoen RM, Plante JA, Plante KS, Weaver SC, Debbink K, Routh AL, Walker D, ... ... Menachery VD, et al. Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge. Biorxiv : the Preprint Server For Biology. PMID 33972939 DOI: 10.1101/2021.05.03.442357  0.4
2021 Vanderheiden A, Thomas J, Soung AL, Davis-Gardner ME, Floyd K, Jin F, Cowan DA, Pellegrini K, Creanga A, Pegu A, Derrien-Colemyn A, Shi PY, Grakoui A, Klein RS, Bosinger SE, ... ... Menachery VD, et al. CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection. Biorxiv : the Preprint Server For Biology. PMID 33972938 DOI: 10.1101/2021.05.03.442538  0.322
2021 Mantus G, Nyhoff LE, Kauffman RC, Edara VV, Lai L, Floyd K, Shi PY, Menachery VD, Edupuganti S, Scherer EM, Kay A, McNair N, Anderson EJ, Rouphael N, Ahmed R, et al. Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain. Journal of Immunology (Baltimore, Md. : 1950). PMID 33952616 DOI: 10.4049/jimmunol.2001420  0.332
2021 Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, Ku Z, An Z, Scharton D, Schindewolf C, Menachery VD, Shi PY, Weaver SC. The N501Y spike substitution enhances SARS-CoV-2 transmission. Biorxiv : the Preprint Server For Biology. PMID 33758836 DOI: 10.1101/2021.03.08.434499  0.329
2021 Zhang X, Liu Y, Liu J, Bailey AL, Plante KS, Plante JA, Zou J, Xia H, Bopp NE, Aguilar PV, Ren P, Menachery VD, Diamond MS, Weaver SC, Xie X, et al. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. PMID 33691138 DOI: 10.1016/j.cell.2021.02.044  0.543
2021 Routhu NK, Cheedarla N, Gangadhara S, Bollimpelli VS, Boddapati AK, Shiferaw A, Rahman SA, Sahoo A, Edara VV, Lai L, Floyd K, Wang S, Fischinger S, Atyeo C, Shin SA, ... ... Menachery VD, et al. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. PMID 33631118 DOI: 10.1016/j.immuni.2021.02.001  0.326
2021 Edara VV, Floyd K, Lai L, Gardner M, Hudson W, Piantadosi A, Waggoner JJ, Babiker A, Ahmed R, Xie X, Lokugamage K, Menachery V, Shi PY, Suthar MS. Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant. Medrxiv : the Preprint Server For Health Sciences. PMID 33564782 DOI: 10.1101/2021.02.02.21250799  0.311
2021 Xie X, Liu Y, Liu J, Zhang X, Zou J, Fontes-Garfias CR, Xia H, Swanson KA, Cutler M, Cooper D, Menachery VD, Weaver SC, Dormitzer PR, Shi PY. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature Medicine. PMID 33558724 DOI: 10.1038/s41591-021-01270-4  0.326
2021 Xie X, Lokugamage KG, Zhang X, Vu MN, Muruato AE, Menachery VD, Shi PY. Engineering SARS-CoV-2 using a reverse genetic system. Nature Protocols. PMID 33514944 DOI: 10.1038/s41596-021-00491-8  0.31
2021 Graham JB, Swarts JL, Leist SR, Schäfer A, Menachery VD, Gralinski LE, Jeng S, Miller DR, Mooney MA, McWeeney SK, Ferris MT, Pardo-Manuel de Villena F, Heise MT, Baric RS, Lund JM. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice. Plos Pathogens. 17: e1009287. PMID 33513210 DOI: 10.1371/journal.ppat.1009287  0.351
2021 Fiege JK, Thiede JM, Nanda HA, Matchett WE, Moore PJ, Montanari NR, Thielen BK, Daniel J, Stanley E, Hunter RC, Menachery VD, Shen SS, Bold TD, Langlois RA. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. Plos Pathogens. 17: e1009292. PMID 33507952 DOI: 10.1371/journal.ppat.1009292  0.342
2021 Zhang X, Liu Y, Liu J, Bailey AL, Plante KS, Plante JA, Zou J, Xia H, Bopp N, Aguilar P, Ren P, Menachery VD, Diamond MS, Weaver SC, Xie X, et al. A -complementation system for SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 33501436 DOI: 10.1101/2021.01.16.426970  0.541
2021 Johnson BA, Xie X, Bailey AL, Kalveram B, Lokugamage KG, Muruato A, Zou J, Zhang X, Juelich T, Smith JK, Zhang L, Bopp N, Schindewolf C, Vu M, Vanderheiden A, ... ... Menachery VD, et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. PMID 33494095 DOI: 10.1038/s41586-021-03237-4  0.467
2020 Vanderheiden A, Edara VV, Floyd K, Kauffman RC, Mantus G, Anderson E, Rouphael N, Edupuganti S, Shi PY, Menachery VD, Wrammert J, Suthar MS. Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Current Protocols in Immunology. 131: e116. PMID 33215858 DOI: 10.1002/cpim.116  0.305
2020 Fiege JK, Thiede JM, Nanda H, Matchett WE, Moore PJ, Montanari NR, Thielen BK, Daniel J, Stanley E, Hunter RC, Menachery VD, Shen SS, Bold TD, Langlois RA. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. Biorxiv : the Preprint Server For Biology. PMID 33106802 DOI: 10.1101/2020.10.19.343954  0.342
2020 Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, Mirchandani D, Scharton D, Bilello JP, Ku Z, An Z, ... ... Menachery VD, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. PMID 33106671 DOI: 10.1038/s41586-020-2895-3  0.351
2020 Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11: 5214. PMID 33060595 DOI: 10.1038/s41467-020-19055-7  0.331
2020 Graham JB, Swarts JL, Leist SR, Schäfer A, Menachery VD, Gralinski LE, Jeng S, Miller DR, Mooney MA, McWeeney SK, Ferris MT, de Villena FP, Heise MT, Baric RS, Lund JM. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection. Biorxiv : the Preprint Server For Biology. PMID 32995791 DOI: 10.1101/2020.09.21.306837  0.363
2020 Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. Evasion of Type I Interferon by SARS-CoV-2. Cell Reports. 108234. PMID 32979938 DOI: 10.1016/J.Celrep.2020.108234  0.42
2020 Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, Rajsbaum R, Menachery VD. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. Journal of Virology. PMID 32938761 DOI: 10.1128/Jvi.01410-20  0.52
2020 Gniadek TJ, Thiede JM, Matchett WE, Gress AR, Pape KA, Fiege JK, Jenkins MK, Menachery VD, Langlois RA, Bold TD. SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with non-severe disease. Transfusion. PMID 32935872 DOI: 10.1111/Trf.16101  0.308
2020 Shi PY, Plante J, Liu Y, Liu J, Xia H, Johnson B, Lokugamage K, Zhang X, Muruato A, Zou J, Fontes-Garfias C, Mirchandani D, Scharton D, Kalveram B, Bilello J, ... ... Menachery V, et al. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility. Research Square. PMID 32935091 DOI: 10.21203/rs.3.rs-70482/v1  0.361
2020 Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, Mirchandani D, Scharton D, Bilello JP, Ku Z, An Z, ... ... Menachery VD, et al. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility. Biorxiv : the Preprint Server For Biology. PMID 32908978 DOI: 10.1101/2020.09.01.278689  0.361
2020 Johnson BA, Xie X, Kalveram B, Lokugamage KG, Muruato A, Zou J, Zhang X, Juelich T, Smith JK, Zhang L, Bopp N, Schindewolf C, Vu M, Vanderheiden A, Swetnam D, ... ... Menachery VD, et al. Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis. Biorxiv : the Preprint Server For Biology. PMID 32869021 DOI: 10.1101/2020.08.26.268854  0.364
2020 Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, Shi PY. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 11: 4059. PMID 32792628 DOI: 10.1038/S41467-020-17892-0  0.345
2020 Prasanth KR, Hirano M, Fagg WS, McAnarney ET, Shan C, Xie X, Hage A, Pietzsch CA, Bukreyev A, Rajsbaum R, Shi PY, Bedford MT, Bradrick SS, Menachery V, Garcia-Blanco MA. Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses. Antiviral Research. 104874. PMID 32735900 DOI: 10.1016/J.Antiviral.2020.104874  0.387
2020 Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, Aoued H, Tharp GM, Pellegrini KL, Manfredi C, Sorscher E, Mainou B, Lobby JL, Kohlmeier JE, Lowen AC, ... ... Menachery VD, et al. Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. Journal of Virology. PMID 32699094 DOI: 10.1128/Jvi.00985-20  0.472
2020 Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Biorxiv : the Preprint Server For Biology. PMID 32607511 DOI: 10.1101/2020.06.22.165712  0.316
2020 Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD. SARS-CoV-2 is sensitive to type I interferon pretreatment. Biorxiv : the Preprint Server For Biology. PMID 32511335 DOI: 10.1101/2020.03.07.982264  0.391
2020 Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y, Uehara A, Wang H, Goldsmith C, Bullock HA, ... ... Menachery VD, et al. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient. Biorxiv : the Preprint Server For Biology. PMID 32511316 DOI: 10.1101/2020.03.02.972935  0.367
2020 Noll KE, Whitmore AC, West A, McCarthy MK, Morrison CR, Plante KS, Hampton BK, Kollmus H, Pilzner C, Leist SR, Gralinski LE, Menachery VD, Schäfer A, Miller D, Shaw G, et al. Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross. Cell Reports. 31: 107587. PMID 32348764 DOI: 10.1016/J.Celrep.2020.107587  0.442
2020 Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, Liu J, Schindewolf C, Bopp NE, Aguilar PV, Plante KS, Weaver SC, Makino S, LeDuc JW, Menachery VD, et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host & Microbe. PMID 32289263 DOI: 10.1016/J.Chom.2020.04.004  0.481
2020 Sandler ZJ, Firpo MR, Omoba OS, Vu MN, Menachery VD, Mounce BC. Novel ionophores active against La Crosse virus identified through rapid antiviral screening. Antimicrobial Agents and Chemotherapy. PMID 32284379 DOI: 10.1128/Aac.00086-20  0.51
2020 Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y, Uehara A, Wang H, Goldsmith C, Bullock HA, ... ... Menachery VD, et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerging Infectious Diseases. 26. PMID 32160149 DOI: 10.3201/Eid2606.200516  0.469
2019 Menachery VD, Dinnon KH, Yount BL, McAnarney ET, Gralinski LE, Hale A, Graham RL, Scobey T, Anthony SJ, Wang L, Graham B, Randell SH, Lipkin WI, Baric RS. Trypsin treatment unlocks barrier for zoonotic bat coronaviruses infection. Journal of Virology. PMID 31801868 DOI: 10.1128/Jvi.01774-19  0.451
2019 Graham JB, Swarts JL, Menachery VD, Gralinski LE, Schäfer A, Plante KS, Morrison CR, Voss KM, Green R, Choonoo G, Jeng S, Miller DR, Mooney MA, McWeeney SK, Ferris MT, et al. Immune predictors of mortality following RNA virus infection. The Journal of Infectious Diseases. PMID 31621854 DOI: 10.1093/Infdis/Jiz531  0.503
2019 Johnson BA, Hage A, Kalveram B, Mears M, Plante JA, Rodriguez SE, Ding Z, Luo X, Bente D, Bradrick SS, Freiberg AN, Popov V, Rajsbaum R, Rossi S, Russell WK, ... Menachery VD, et al. Peptidoglycan associated cyclic lipopeptide disrupts viral infectivity. Journal of Virology. PMID 31462558 DOI: 10.1128/Jvi.01282-19  0.482
2019 Dinnon Iii KH, Gallichotte EN, Fritch EJ, Menachery VD, Baric RS. Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity. Plos Neglected Tropical Diseases. 13: e0007212. PMID 30845254 DOI: 10.1371/Journal.Pntd.0007212  0.376
2019 Schindewolf C, Menachery VD. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses. 11. PMID 30658390 DOI: 10.3390/V11010074  0.314
2018 van Doremalen N, Schäfer A, Menachery VD, Letko M, Bushmaker T, Fischer RJ, Figueroa DM, Hanley PW, Saturday G, Baric RS, Munster VJ. SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (). Viruses. 10. PMID 30572566 DOI: 10.3390/V10120727  0.468
2018 Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. Mbio. 9. PMID 30301856 DOI: 10.1128/Mbio.01753-18  0.48
2018 Menachery VD, Gralinski LE, Mitchell HD, Dinnon KH, Leist SR, Yount BL, McAnarney ET, Graham RL, Waters KM, Baric RS. Combination attenuation offers strategy for live-attenuated coronavirus vaccines. Journal of Virology. PMID 29976657 DOI: 10.1128/Jvi.00710-18  0.352
2018 Agnihothram S, Menachery VD, Yount BL, Lindesmith LC, Scobey T, Whitmore A, Schäfer A, Heise MT, Baric RS. Development of a Broadly Accessible VEE Replicon Particle Vaccine Platform. Journal of Virology. PMID 29540599 DOI: 10.1128/Jvi.00027-18  0.367
2018 Menachery VD, Schäfer A, Burnum-Johnson KE, Mitchell HD, Eisfeld AJ, Walters KB, Nicora CD, Purvine SO, Casey CP, Monroe ME, Weitz KK, Stratton KG, Webb-Robertson BM, Gralinski LE, Metz TO, et al. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proceedings of the National Academy of Sciences of the United States of America. PMID 29339515 DOI: 10.1073/Pnas.1706928115  0.504
2017 Johnson BA, Graham RL, Menachery VD. Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses. Virology. PMID 29279138 DOI: 10.1016/J.Virol.2017.12.009  0.363
2017 Menachery VD, Gralinski LE, Mitchell HD, Dinnon KH, Leist SR, Yount BL, Graham RL, McAnarney ET, Stratton KG, Cockrell AS, Debbink K, Sims AC, Waters KM, Baric RS. Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis. Msphere. 2. PMID 29152578 DOI: 10.1128/mSphere.00346-17  0.419
2017 Gallichotte EN, Dinnon KH, Lim XN, Ng TS, Lim EXY, Menachery VD, Lok SM, Baric RS. CD-loop extension in Zika virus envelope protein key for stability and pathogenesis. The Journal of Infectious Diseases. PMID 28968838 DOI: 10.1093/Infdis/Jix473  0.422
2017 Menachery VD, Mitchell HD, Cockrell AS, Gralinski LE, Yount BL, Graham RL, McAnarney ET, Douglas MG, Scobey T, Beall A, Dinnon K, Kocher JF, Hale AE, Stratton KG, Waters KM, et al. MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis. Mbio. 8. PMID 28830941 DOI: 10.1128/Mbio.00665-17  0.528
2017 Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Science Translational Medicine. 9. PMID 28659436 DOI: 10.1126/Scitranslmed.Aal3653  0.517
2017 Gralinski LE, Menachery VD, Morgan AP, Totura AL, Beall A, Kocher J, Plante J, Harrison-Shostak DC, Schäfer A, Pardo-Manuel de Villena F, Ferris MT, Baric RS. Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice. G3 (Bethesda, Md.). 7: 1653-1663. PMID 28592648 DOI: 10.1534/G3.117.041434  0.446
2017 Anthony SJ, Gilardi K, Menachery VD, Goldstein T, Ssebide B, Mbabazi R, Navarrete-Macias I, Liang E, Wells H, Hicks A, Petrosov A, Byarugaba DK, Debbink K, Dinnon KH, Scobey T, et al. Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus. Mbio. 8. PMID 28377531 DOI: 10.1128/Mbio.00373-17  0.465
2017 Gallichotte EN, Menachery VD, Yount BL, Widman DG, Dinnon KH, Hartman S, de Silva AM, Baric RS. Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone. Msphere. 2. PMID 28251184 DOI: 10.1128/mSphere.00380-16  0.417
2017 Menachery VD, Graham RL, Baric RS. Jumping species-a mechanism for coronavirus persistence and survival. Current Opinion in Virology. 23: 1-7. PMID 28214731 DOI: 10.1016/J.Coviro.2017.01.002  0.353
2016 Menachery VD, Yount BL, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, et al. SARS-like WIV1-CoV poised for human emergence. Proceedings of the National Academy of Sciences of the United States of America. PMID 26976607 DOI: 10.1073/Pnas.1517719113  0.509
2015 Menachery VD. MERS Vaccine Candidate Offers Promise, but Questions Remain. Ebiomedicine. 2: 1292-3. PMID 26629514 DOI: 10.1016/J.Ebiom.2015.09.037  0.412
2015 Menachery VD, Yount BL, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature Medicine. PMID 26552008 DOI: 10.1038/Nm.3985  0.546
2015 Gralinski LE, Ferris MT, Aylor DL, Whitmore AC, Green R, Frieman MB, Deming D, Menachery VD, Miller DR, Buus RJ, Bell TA, Churchill GA, Threadgill DW, Katze MG, McMillan L, et al. Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. Plos Genetics. 11: e1005504. PMID 26452100 DOI: 10.1371/Journal.Pgen.1005504  0.384
2015 Menachery VD, Gralinski LE, Baric RS, Ferris MT. New Metrics for Evaluating Viral Respiratory Pathogenesis. Plos One. 10: e0131451. PMID 26115403 DOI: 10.1371/Journal.Pone.0131451  0.515
2014 Aevermann BD, Pickett BE, Kumar S, Klem EB, Agnihothram S, Askovich PS, Bankhead A, Bolles M, Carter V, Chang J, Clauss TR, Dash P, Diercks AH, Eisfeld AJ, Ellis A, ... ... Menachery V, et al. A comprehensive collection of systems biology data characterizing the host response to viral infection. Scientific Data. 1: 140033. PMID 25977790 DOI: 10.1038/Sdata.2014.33  0.42
2014 Selinger C, Tisoncik-Go J, Menachery VD, Agnihothram S, Law GL, Chang J, Kelly SM, Sova P, Baric RS, Katze MG. Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates. Bmc Genomics. 15: 1161. PMID 25534508 DOI: 10.1186/1471-2164-15-1161  0.503
2014 Menachery VD, Debbink K, Baric RS. Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments. Virus Research. 194: 191-9. PMID 25278144 DOI: 10.1016/J.Virusres.2014.09.009  0.439
2014 Menachery VD, Eisfeld AJ, Schäfer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. Mbio. 5: e01174-14. PMID 24846384 DOI: 10.1128/Mbio.01174-14  0.517
2014 Agnihothram S, Yount BL, Donaldson EF, Huynh J, Menachery VD, Gralinski LE, Graham RL, Becker MM, Tomar S, Scobey TD, Osswald HL, Whitmore A, Gopal R, Ghosh AK, Mesecar A, et al. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. Mbio. 5: e00047-14. PMID 24667706 DOI: 10.1128/Mbio.00047-14  0.497
2014 Menachery VD, Yount BL, Josset L, Gralinski LE, Scobey T, Agnihothram S, Katze MG, Baric RS. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity. Journal of Virology. 88: 4251-64. PMID 24478444 DOI: 10.1128/Jvi.03571-13  0.492
2014 Agnihothram S, Gopal R, Yount BL, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. The Journal of Infectious Diseases. 209: 995-1006. PMID 24253287 DOI: 10.1093/Infdis/Jit609  0.485
2013 Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proceedings of the National Academy of Sciences of the United States of America. 110: 16157-62. PMID 24043791 DOI: 10.1073/Pnas.1311542110  0.469
2013 Menachery VD, Baric RS. Bugs in the system. Immunological Reviews. 255: 256-74. PMID 23947361 DOI: 10.1111/Imr.12092  0.4
2013 Gralinski LE, Bankhead A, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, et al. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. Mbio. 4. PMID 23919993 DOI: 10.1128/Mbio.00271-13  0.475
2013 Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. Mbio. 4: e00165-13. PMID 23631916 DOI: 10.1128/Mbio.00165-13  0.511
2013 Sims AC, Tilton SC, Menachery VD, Gralinski LE, Schäfer A, Matzke MM, Webb-Robertson BJ, Chang J, Luna ML, Long CE, Shukla AK, Bankhead AR, Burkett SE, Zornetzer G, Tseng CT, et al. Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. Journal of Virology. 87: 3885-902. PMID 23365422 DOI: 10.1128/Jvi.02520-12  0.53
2012 Pasieka TJ, Menachery VD, Rosato PC, Leib DA. Corneal replication is an interferon response-independent bottleneck for virulence of herpes simplex virus 1 in the absence of virion host shutoff. Journal of Virology. 86: 7692-5. PMID 22553331 DOI: 10.1128/Jvi.00761-12  0.464
2012 Menachery V, Sims A, Eisfeld A, Gralinski L, Chang J, Waters K, Metz T, Kawaoka Y, Katze M, Baric R. P115 Pathogenic Influenza A viruses and SARS-Coronaviruses modulate global interferon stimulated gene induction through diverse mechanisms Cytokine. 59: 556. DOI: 10.1016/J.Cyto.2012.06.206  0.539
2010 Menachery VD, Pasieka TJ, Leib DA. Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. Journal of Virology. 84: 9685-94. PMID 20660188 DOI: 10.1128/Jvi.00706-10  0.441
2009 Menachery VD, Leib DA. Control of herpes simplex virus replication is mediated through an interferon regulatory factor 3-dependent pathway. Journal of Virology. 83: 12399-406. PMID 19759149 DOI: 10.1128/Jvi.00888-09  0.443
2008 Pasieka TJ, Lu B, Crosby SD, Wylie KM, Morrison LA, Alexander DE, Menachery VD, Leib DA. Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. Journal of Virology. 82: 5527-35. PMID 18367525 DOI: 10.1128/Jvi.02047-07  0.502
Show low-probability matches.